Prevention of Lateral Incisional Hernia After Stomal Closure Using P4HB Retro-muscular Mesh

Overview

The aim of the study is to determine whether the use of the P4HB retro muscular mesh can prevent the lateral incisional hernia after stomal closure.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2021

Interventions

  • Procedure: Mesh augmentation
    • P4HB retromuscular mesh placement for prevention of lateral incisional hernia after stomal closure
  • Procedure: Direct suture
    • direct fascia suture

Arms, Groups and Cohorts

  • Experimental: Mesh Augmentated
  • Other: Direct Suture

Clinical Trial Outcome Measures

Primary Measures

  • rate of postoperative lateral incisional hernia after P4HB mesh placement vs direct fascia suture.
    • Time Frame: 1 week to 18 months after surgery
    • the outcome 1 will be assessed through clinical examination during follow up time. when the suspicion of incisional hernia will be hypothesized the patients will be conducted to perform US of the abdomen and CT scan of the abdomen if strictly required to confirm the suspicion.

Secondary Measures

  • surgical operation time in P4HB mesh placement group vs direct fascia suture group.
    • Time Frame: intraoperative
    • outcome 2 will be assessed through the measurement of the length of surgical operation. The length of the surgical operation will be measured in minutes from the incision of the skin to the suture of the skin. data will be compared with those of the control arm (direct fascia suture) to understand the feasibility of the technique proposed.
  • length of hospital stay in P4HB mesh placement group vs direct fascia suture group.
    • Time Frame: From the starting date of the study until the date of its completion, assessed up to 18 months”
    • outcome 3 will be assessed through the measurement of the length of the hospital stay. The length of hospital stay will be measured in days from admission to dimission of the patient. Data will be compared with those of the control arm (direct fascia suture).
  • rate of surgical site infection in P4HB mesh placement group vs direct fascia suture group.
    • Time Frame: 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
    • outcome 4 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complication such as surgical site infection.
  • rate of seroma formation in P4HB mesh placement group vs direct fascia suture group.
    • Time Frame: 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
    • outcome 5 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complications such as seroma.
  • rate of hematoma formation in P4HB mesh placement group vs direct fascia suture group.
    • Time Frame: 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
    • outcome 6 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complications such as hematoma.
  • assessment of quality of life (QoL) through QoL scale in P4HB mesh placement group vs direct fascia suture group.
    • Time Frame: 18 months after surgery.
    • outcome 7 will be assessed through assessment of the postoperative QoL. The SF-36 questionnaire will be administered post-operatively. The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. The SF-36, as described in the name, is a 36-item patient-reported questionnaire that covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.
  • cost effectiveness analysis of the P4HB mesh augmentation technique vs direct fascia suture group.
    • Time Frame: through study completion, an average of 1 year .
    • the outcome 8 will be assessed through the collection of data about the total costs for the surgical operation and the hospitalization considering materials and mesh used. The analysis will be used to compare the costs of the technique proposed with those of the incisional hernia management in order to conduct a cost effectiveness analysis.

Participating in This Clinical Trial

Inclusion Criteria

  • patients > 18 y.o. – stomal closure – elective surgery Exclusion Criteria:

  • patients < 18 y.o. – emergency surgery

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Buccheri La Ferla Hospital, Palermo
  • Provider of Information About this Clinical Study
    • Principal Investigator: Leo Licari, Principal Investigator – Buccheri La Ferla Hospital, Palermo
  • Overall Official(s)
    • Leo Licari, MD, Study Director, Ospedale Buccheri La Ferla Palermo; University of Palermo – Department of Surgical, Oncological and Oral Sciences
    • Cosimo Callari, MD, Study Chair, Ospedale Buccheri La Ferla Palermo
  • Overall Contact(s)
    • Leo Licari, MD, +39 3401710089, lele.licari@gmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.